Myopia Treatment Devices Market Size, Growth & Demand by 2034

Coverage: By Product Type (Eyeglasses, Contact Lenses, Phakic Intraocular Lenses, and Laser Refractive Surgery Devices), Treatment Type (Corrective Lenses, Laser Surgery, Lens Implant Surgery), Component (Devices and Services), End-Use Industry (Ophthalmic Clinics, Hospitals, Retail Optical Chains, and Online Platforms), and Geography (North America, Europe, Asia Pacific, the Middle East and Africa, and South and Central America)

Historic Data: 2021-2024 | Base Year: 2025 | Forecast Period: 2026-2034
  • Status : Upcoming
  • Report Code : TIPRE00043086
  • Category : Life Sciences
  • No. of Pages : 150
  • Available Report Formats : pdf-format excel-format
  • Last update date : March 04, 2026
Myopia Treatment Devices Market Size, Growth & Demand by 2034
Report Date: March 04, 2026   |   Report Code: TIPRE00043086 Email: sales@theinsightpartners.com

2025 Market Size

US$ 17.45 Bn

Base year value

2034 Forecast

US$ 30.66 Bn

Projected by 2034

CAGR 2026-2034

6.46 %

Growth rate

Addressable Market

US$ 217.58 Bn

(2026-2034)

The myopia treatment devices market size is expected to reach USD 30.66 billion by 2034 from USD 17.45 billion in 2025. The market is anticipated to register a CAGR of 6.46% during 2026–2034.

Myopia Treatment Devices Market Analysis

The myopia treatment devices market is expanding due to the rising prevalence of myopia globally, especially among children and adolescents. Increased screen time, urban lifestyles, and awareness of early intervention are driving demand for corrective and control devices. Technological advancements in orthokeratology lenses, low-dose atropine delivery systems, and refractive surgery equipment are creating new opportunities. The market is also supported by growing middle-class spending in emerging economies and the adoption of AI-enabled diagnostics and tele-ophthalmology platforms.

Myopia Treatment Devices Market Overview

Myopia treatment devices include eyeglasses, contact lenses (orthokeratology, multifocal), phakic intraocular lenses, and laser refractive surgery systems. These devices are used to correct vision and slow the progression of myopia. The market is driven by increasing awareness of early treatment, technological innovation, and rising demand for pediatric myopia control solutions.

Market Assessment and Insights

  • Global market for Myopia Treatment Devices was valued at US$ 17.45 Billion in 2025
  • Annual market size is expected to reach US$ 30.66 Billion by 2034
  • Total addressable market (TAM) during 2026-2034 is projected to reach approximately US$ 217.58 Billion
  • Market is anticipated to register a CAGR of 6.46% during the forecast period
  • The United States represents a key market, supported by Increasing prevalence of myopia, especially among children and adolescents, Growing adoption of non-invasive devices to slow myopia progression, Rising awareness among parents and healthcare providers about eye care, as well as evolving industry dynamics
  • Market analysis covers North America, Europe, Asia-Pacific, South and Central America, Middle East and Africa, with growth evaluated across the forecast period
  • Market opportunities such as Development of wearable and optical devices for effective myopia management, Partnerships with ophthalmology clinics and vision centers to expand device reach, Integration of telehealth platforms to monitor treatment adherence and outcomes are expected to influence market dynamics and addressable market
  • Report profiles industry participants, including CooperVision- United States, Johnson & Johnson Vision- United States, EssilorLuxottica- France, Bausch & Lomb- United States, Menicon- Japan, Alcon- Switzerland, HOYA Vision Care- Japan, SynergEyes- United States, STAAR Surgical- United States, NIDEK- Japan, while analyzing competitive strategies and innovation developments
  • Source: The Insight Partners' analysis based on proprietary research, government publications, company annual reports, investor presentations, industry databases, and expert interviews.

● REPORT CUSTOMIZATION

Tailor This Report To Align With Your Specific Business Requirements

This report can be customized to align precisely with your business objectives, scope, and target markets. Customization options include tailored segmentation, geography, competitive analysis, and strategic insights to support informed decision-making.

Customize This Report →

WHAT YOU CAN ADJUST

  • Segmentations
  • Geography
  • Competitive Analysis
  • Language Preferences

Myopia Treatment Devices Market: Strategic Insights

myopia-treatment-devices-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Myopia Treatment Devices Market Drivers and Opportunities

Market Drivers:

  • Increasing Prevalence of Myopia Globally: The fast emergence of myopia, especially in the younger populations, which is due to increased screen exposure and urban lifestyles, requires the adoption of treatment and control devices.
  • Improved Awareness of Early Intervention: Increasing public and professional awareness of the long-term complications related to high myopia is driving interest in preventing and slowing the progression with therapies such as low-dose atropine and special contact lenses.
  • Myopia Control: With continuous innovations in smart optical lenses, AI-driven diagnostic tools for the prediction of progression, and advances in laser refractive systems, a wider and more effective range of treatment options is emerging.

Market Opportunities:

  • Pediatric treatment segment growth: Early-life myopia control forms an exciting frontier of opportunity in specialized products such as Orthokeratology (Ortho-K) lenses and therapeutic drug-device combinations for children.     
  • Rising Disposable Income in Emerging Markets: Increased economic prosperity in regions such as the Asia Pacific creates a corresponding rise in disposable income, hence allowing patients to afford premium and advanced treatment devices that go beyond basic corrective eyeglasses to specialized control therapies.
  • Integration of AI, Telemedicine, and Personalized Care: Utilizing AI and remote monitoring platforms allows practitioners to deliver personalized treatment protocols and efficiently manage large populations, creating new service delivery opportunities.

Myopia Treatment Devices Market Report Segmentation Analysis

The myopia treatment devices market share is analyzed across various segments to provide a clearer understanding of its structure, growth potential, and emerging trends. Below is the standard segmentation approach used in most industry reports:

By Product Type:

  • Eyeglasses
  • Contact Lenses (Orthokeratology, Multifocal)
  • Phakic Intraocular Lenses (IOLs)
  • Laser Refractive Surgery Devices

By Treatment Type:

  • Corrective Lenses
  • Laser Surgery
  • Lens Implant Surgery

By Component:

  • Devices
  • Services

By End-Use Industry:

  • Ophthalmic Clinics
  • Hospitals
  • Retail Optical Chains
  • Online Platforms

By Geography:

  • North America
  • Europe
  • Asia Pacific
  • South & Central America
  • Middle East & Africa

The myopia treatment devices market in the Asia Pacific is expected to witness the largest regional share during the forecast period, driven by the extremely high prevalence of myopia and rising disposable income.

Myopia Treatment Devices Market Report Scope

Report Attribute Details
Market size in 2025 US$ 17.45 Billion
Market Size by 2034 US$ 30.66 Billion
Global CAGR (2026 - 2034) 6.46%
Historical Data 2021-2024
Forecast period 2026-2034
Segments Covered By Product Type
  • Eyeglasses
  • Contact Lenses
  • Phakic Intraocular Lenses
  • Laser Refractive Surgery Devices
By Treatment Type
  • Corrective Lenses
  • Laser Surgery
  • Lens Implant Surgery
By Component
  • Devices
  • Services
By End-Use Industry
  • Ophthalmic Clinics
  • Hospitals
  • Retail Optical Chains
  • Online Platforms
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • CooperVision- United States
  • Johnson & Johnson Vision- United States
  • EssilorLuxottica- France
  • Bausch & Lomb- United States
  • Menicon- Japan
  • Alcon- Switzerland
  • HOYA Vision Care- Japan
  • SynergEyes- United States
  • STAAR Surgical- United States
  • NIDEK- Japan

Myopia Treatment Devices Market Players Density: Understanding Its Impact on Business Dynamics

The Myopia Treatment Devices Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

myopia-treatment-devices-market-cagr

Myopia Treatment Devices Market Share Analysis by Geography

Asia Pacific is expected to grow fastest in the coming years. Emerging markets in South & Central America, the Middle East, and Africa also have many untapped opportunities for treatment device providers to expand. The myopia treatment devices market shows a different growth trajectory in each region due to factors such as disease prevalence, healthcare infrastructure, and technology adoption. Below is a summary of market share and trends by region:  

North America

  • Market Share: Fastest-growing region due to advanced infrastructure and strong R&D focus.
  • Key Drivers:
    • High adoption of refractive surgery and smart lenses
    • Strong regulatory support for advanced medical devices
    • High patient awareness and disposable income
  • Trends: Integration of AI diagnostics and tele-ophthalmology platforms to enhance patient monitoring and treatment efficacy.

Europe

  • Market Share: Significant share due to established healthcare systems and focus on pediatric health.       
  • Key Drivers:
    • Government support for pediatric eye health and preventive care
    • High innovation in specialized contact lenses
    • Favorable reimbursement policies for advanced treatments        
  • Trends: Increasing adoption of ortho-K lenses and low-dose atropine therapies for myopia control.

Asia Pacific

  • Market Share: Largest regional share, dominating the global market volume.
  • Key Drivers:
    • The highest prevalence of myopia is especially in children
    • Rapidly expanding middle-class spending on premium healthcare
    • Government initiatives promoting eye health
  • Trends: Rapid adoption of myopia control devices and significant capacity expansion by local and international manufacturers.

4. South & Central America

  • Market Share: Emerging market with high growth potential.
  • Key Drivers:
    • Expansion of private eye care clinics and specialist centers
    • Increasing urbanization and lifestyle changes are driving myopia rates
    • Growing demand for affordable corrective devices
  • Trends: Focus on entry-level and affordable corrective solutions alongside gradual adoption of advanced control technologies.

5. Middle East & Africa

  • Market Share: Developing market, expected to show strong growth post-2025.
  • Key Drivers:
    • Rising healthcare investments and national health strategies
    • Rapid urbanization and demographic shifts
    • Growing demand for refractive surgery options
  • Trends: Gradual adoption of advanced refractive surgery techniques and expansion of retail optical chains across urban centers.

Myopia Treatment Devices Market Players Density: Understanding Its Impact on Business Dynamics

High Market Density and Competition

The market is highly competitive with global players such as CooperVision, Johnson & Johnson Vision, EssilorLuxottica, Bausch & Lomb, Menicon, Alcon, HOYA Vision Care, SynergEyes, STAAR Surgical, and NIDEK.

Differentiation Strategies:       

  • Pediatric-focused product innovation, including highly specialized ortho-K lenses and multifocal contact lens designs.
  • Smart drug-device combinations that integrate low-dose atropine delivery with monitoring systems for maximum efficacy.
  • Expansion into emerging markets by establishing localized manufacturing and distribution channels to capture high-growth patient pools.
  • AI-enabled diagnostics and remote monitoring platforms to offer personalized treatment plans and track progression over time.

Opportunities and Strategic Moves

  • Strategic partnerships with ophthalmic clinics and optometrists to enhance product adoption and training.
  • Focus on non-invasive or minimally invasive solutions to appeal to parents and increase compliance in children.
  • Incorporate remote data monitoring capabilities to improve patient adherence and clinical outcomes.

Major Companies operating in the Myopia Treatment Devices Market are:

  • CooperVision- United States
  • Johnson & Johnson Vision- United States
  • EssilorLuxottica- France
  • Bausch & Lomb- United States
  • Menicon- Japan
  • Alcon- Switzerland
  • HOYA Vision Care- Japan
  • SynergEyes- United States
  • STAAR Surgical- United States
  • NIDEK- Japan  

Disclaimer: The companies listed above are not ranked in any particular order.

Myopia Treatment Devices Market News and Recent Developments

  • CooperVision, a global leader in contact lens innovation, announced seven-year clinical validation of its MiSight® 1 day lenses.- CooperVision, a global leader in contact lens innovation, announced that a peer-reviewed study published in Optometry and Vision Science confirmed sustained myopia control with MiSight® 1-day lenses, even one year after discontinuation. The findings support routine pediatric use and reinforce CooperVision’s leadership in myopia management.
  • EssilorLuxottica received FDA authorization for its Stellest™ spectacle lenses to slow myopia progression in children.-EssilorLuxottica announced that Stellest™ lenses became the first spectacle lens to receive De Novo authorization from the U.S. FDA for slowing myopia progression in children. Six-year clinical data showed a 57% reduction in progression, positioning Stellest™ as a breakthrough in pediatric myopia care.

Myopia Treatment Devices Market Report Coverage and Deliverables

The "Myopia Treatment Devices Market Size and Forecast (2021–2034)" report provides a detailed analysis of the market covering below areas:

  • Myopia Treatment Devices Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Myopia Treatment Devices Market trends, as well as market dynamics such as drivers, restraints, and key opportunities
  • Detailed PEST and SWOT analysis
  • Myopia Treatment Devices Market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
  • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments in the Myopia Treatment Devices Market
  • Detailed company profiles

Frequently Asked Questions

The market features major global vision companies, including CooperVision, Johnson & Johnson Vision, EssilorLuxottica, Bausch & Lomb, and HOYA Vision Care, which compete across the corrective and control device segments.

Technology is critical, focusing on innovations like ortho-K lenses (worn overnight to reshape the cornea), low-dose atropine delivery systems, and the integration of AI-enabled diagnostics and telemedicine for personalized and early intervention strategies.

Asia Pacific holds the largest regional market share due to the highest prevalence of myopia globally, particularly among school-age children, combined with increasing middle-class spending on effective treatment devices.

Eyeglasses typically hold the largest share of the market due to their widespread use for vision correction. However, specialized devices like orthokeratology (ortho-K) lenses are the fastest-growing segment, driven by the need for myopia control in children.

The market is driven by the escalating global prevalence of myopia (especially in children), increased awareness of early intervention methods, and rapid technological advancements in specialized contact lenses and surgical systems.
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Comprehensive Market Sizing and Forecast Analysis
  • Detailed Segmentation Analysis
  • In-Depth Market Dynamics Assessment
  • Regional and Country-Level Insights
  • Competitive Landscape and Company Benchmarking
  • Strategic Business Intelligence

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
DUNS Logo
ISO Certified Logo
GDPR
CCPA